title: Left atrial appendage occlusion debate revisited.
authors.affiliation: From Population Health Research Institute, McMaster University, Hamilton, ON, Canada (R.P.W., J.S.H.); and Mayo Clinic, Rochester, MN (D.R.H.). richard.whitlock@phri.ca.
authors.forename: Richard P
authors.initials: RP
authors.lastname: Whitlock
authors.affiliation: From Population Health Research Institute, McMaster University, Hamilton, ON, Canada (R.P.W., J.S.H.); and Mayo Clinic, Rochester, MN (D.R.H.).
authors.forename: Jeff S
authors.initials: JS
authors.lastname: Healey
authors.affiliation: From Population Health Research Institute, McMaster University, Hamilton, ON, Canada (R.P.W., J.S.H.); and Mayo Clinic, Rochester, MN (D.R.H.).
authors.forename: David R
authors.initials: DR
authors.lastname: Holmes
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D020517:Atrial Appendage / Q000601:surgery*; D001281:Atrial Fibrillation / Q000150:complications; D062906:Cardiac Catheters; D006325:Heart Atria / Q000601:surgery*; D006801:Humans; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D060205:Therapeutic Occlusion / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants
keywords: appendage; atrial fibrillation; stroke